Olomoucine is primarily utilized in biological and biochemical research as a potent inhibitor of cyclin-dependent kinases (CDKs). Its application is significant in studying cell cycle regulation, as it effectively halts the progression of the cell cycle by inhibiting CDK activity. This property makes it a valuable tool in cancer research, where understanding and controlling cell proliferation is crucial. Additionally, olomoucine is used in experiments aimed at exploring the mechanisms of apoptosis and cellular differentiation, providing insights into potential therapeutic strategies for various diseases. Its ability to modulate CDK function also aids in the investigation of signal transduction pathways and the development of targeted cancer therapies.